OrbiMed’s ARS Pharmaceuticals SPRY Stock Holding History

OrbiMed’s Portfolio SPRY Stock Details SPRY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$66.6M	Hold	8,288,510	–	–	1.32%	21
2025 Q4	$96.6M	Hold	8,288,510	–	–	1.97%	14
2025 Q3	$83.3M	Hold	8,288,510	–	–	1.96%	15
2025 Q2	$145M	Hold	8,288,510	–	–	3.61%	7
2025 Q1	$104M	Hold	8,288,510	–	–	2.49%	11
2024 Q4	$87.4M	Hold	8,288,510	–	–	1.8%	16
2024 Q3	$120M	Sell	8,288,510 -952,377	-10%	-$11.3M	2.18%	11
2024 Q2	$78.6M	Hold	9,240,887	–	–	1.55%	17
2024 Q1	$94.4M	Hold	9,240,887	–	–	1.73%	15
2023 Q4	$50.6M	Hold	9,240,887	–	–	1.01%	34
2023 Q3	$34.9M	Buy	9,240,887 +500,000	+6%	+$3.28M	0.74%	50
2023 Q2	$58.6M	Hold	8,740,887	–	–	1.06%	36
2023 Q1	$56.9M	Hold	8,740,887	–	–	1.12%	29
2022 Q4	$74.6M	Hold	8,740,887	–	–	1.43%	24
2022 Q3	$46.2K	Hold	8,740,887	–	–	0.86%	44
2022 Q2	$37.1K	Hold	8,740,887	–	–	0.67%	47
2022 Q1	$30.7M	Hold	8,740,887	–	–	0.5%	53
2021 Q4	$58.2M	Hold	8,740,887	–	–	0.75%	44
2021 Q3	$87.2M	Hold	8,740,887	–	–	0.96%	30
2021 Q2	$270M	Hold	8,740,887	–	–	2.73%	8
2021 Q1	$381M	Hold	8,740,887	–	–	3.57%	5
2020 Q4	$405M	Buy	+8,740,887	New	+$292M	3.54%	4

Other funds holding SPRY

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Millennium Management

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

SR One Capital Management Wayne, Pennsylvania $915M AUM 209.71% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Franklin Resources

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Tyro Capital Management Miami, Florida $921M AUM 60.37% 1-Year Est. Return